160 related articles for article (PubMed ID: 17955278)
41. Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up.
Huerta-Sil G; Casasola-Vargas JC; Londoño JD; Rivas-Ruíz R; Chávez J; Pacheco-Tena C; Cardiel MH; Vargas-Alarcón G; Burgos-Vargas R
Ann Rheum Dis; 2006 May; 65(5):642-6. PubMed ID: 16219705
[TBL] [Abstract][Full Text] [Related]
42. Semaphorin 3A in Ankylosing Spondylitis.
Liao HT; Lin YF; Chou CT; Tsai CY
J Microbiol Immunol Infect; 2019 Feb; 52(1):151-157. PubMed ID: 28736223
[TBL] [Abstract][Full Text] [Related]
43. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
[TBL] [Abstract][Full Text] [Related]
44. Is spinal mobility in patients with spondylitis determined by age, structural damage, and inflammation?
Calvo-Gutierrez J; Garrido-Castro JL; Gil-Cabezas J; Gonzalez-Navas C; Ugalde PF; Carmona L; Collantes-Estevez E
Arthritis Care Res (Hoboken); 2015 Jan; 67(1):74-9. PubMed ID: 25049194
[TBL] [Abstract][Full Text] [Related]
45. Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study.
Inman RD; Baraliakos X; Hermann KA; Braun J; Deodhar A; van der Heijde D; Xu S; Hsu B
Arthritis Res Ther; 2016 Dec; 18(1):304. PubMed ID: 28031053
[TBL] [Abstract][Full Text] [Related]
46. Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis.
Ariza-Ariza R; Hernández-Cruz B; Navarro-Sarabia F
Arthritis Rheum; 2003 Aug; 49(4):483-7. PubMed ID: 12910553
[TBL] [Abstract][Full Text] [Related]
47. Is disease severity in ankylosing spondylitis genetically determined?
Hamersma J; Cardon LR; Bradbury L; Brophy S; van der Horst-Bruinsma I; Calin A; Brown MA
Arthritis Rheum; 2001 Jun; 44(6):1396-400. PubMed ID: 11407700
[TBL] [Abstract][Full Text] [Related]
48. Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS).
Kim HR; Lee SH; Kim HY
Rheumatology (Oxford); 2006 Oct; 45(10):1197-200. PubMed ID: 16567356
[TBL] [Abstract][Full Text] [Related]
49. Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis.
Serdaroğlu Beyazal M; Erdoğan T; Türkyılmaz AK; Devrimsel G; Cüre MC; Beyazal M; Sahin I
Clin Rheumatol; 2016 Sep; 35(9):2235-41. PubMed ID: 26847856
[TBL] [Abstract][Full Text] [Related]
50. The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity.
Ozer HT; Sarpel T; Gulek B; Alparslan ZN; Erken E
Clin Rheumatol; 2005 Apr; 24(2):123-8. PubMed ID: 15340866
[TBL] [Abstract][Full Text] [Related]
51. Relationship of work disability between the disease activity, depression and quality of life in patients with ankylosing spondylitis.
Sağ S; Nas K; Sağ MS; Tekeoğlu İ; Kamanlı A
J Back Musculoskelet Rehabil; 2018; 31(3):499-505. PubMed ID: 29504521
[TBL] [Abstract][Full Text] [Related]
52. Reliability and validity of the Thai version of bath ankylosing spondylitis indices.
Kittiyanpanya C; Chaiamnuay S; Asavatanabodee P; Narongroeknawin P
J Med Assoc Thai; 2014 Apr; 97(4):381-5. PubMed ID: 24964679
[TBL] [Abstract][Full Text] [Related]
53. Validation of the Tunisian versions of Bath Ankylosing Spondylitis Functional Index (BASFI) and Disease Activity Index (BASDAI).
Kchir MM; Hamdi W; Kochbati S; Azzouz D; Daoud L; Saadellaoui K; Ghannouchi MM; Kaffel D; Ben Hamida A; Zouari B
Tunis Med; 2009 Aug; 87(8):527-30. PubMed ID: 20180357
[TBL] [Abstract][Full Text] [Related]
54. The effect of smoking on clinical and radiographic variables, and acute phase reactants in patients with ankylosing spondylitis.
Sakellariou GT; Anastasilakis AD; Kenanidis E; Potoupnis M; Tsiridis E; Savvidis M; Kartalis N; Sayegh FE
Rheumatol Int; 2015 Dec; 35(12):2109-14. PubMed ID: 26474866
[TBL] [Abstract][Full Text] [Related]
55. Assessment of fatigue in patients with ankylosing spondylitis.
Turan Y; Duruöz MT; Bal S; Guvenc A; Cerrahoglu L; Gurgan A
Rheumatol Int; 2007 Jul; 27(9):847-52. PubMed ID: 17252263
[TBL] [Abstract][Full Text] [Related]
56. Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage.
Almodóvar R; Carmona L; Zarco P; Collantes E; González C; Mulero J; Sueiro JL; Gratacós J; Torre-Alonso JC; Juanola X; Batlle E; Ariza R; Font P
Clin Exp Rheumatol; 2010; 28(6 Suppl 63):S33-9. PubMed ID: 21176420
[TBL] [Abstract][Full Text] [Related]
57. Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis.
Hu Z; Xu M; Li Q; Lin Z; Liao Z; Cao S; Wei Q; Zhang YL; Li T; Jin O; Huang J; Pan Y; Wu Y; Deng X; Gu J
Int J Rheum Dis; 2012 Aug; 15(4):358-65. PubMed ID: 22898215
[TBL] [Abstract][Full Text] [Related]
58. Relationship between spinal mobility and disease activity, function, quality of life and radiology. A cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER).
Almodóvar R; Zarco P; Collantes E; González C; Mulero J; Fernández-Sueiro JL; Gratacós J; Torres-Alonso JC; Juanola X; Batlle E; Ariza R; Muñoz E
Clin Exp Rheumatol; 2009; 27(3):439-45. PubMed ID: 19604436
[TBL] [Abstract][Full Text] [Related]
59. Serum melatonin level in ankylosing spondylitis: is it increased in active disease?
Senna MK; Olama SM; El-Arman M
Rheumatol Int; 2012 Nov; 32(11):3429-33. PubMed ID: 22057142
[TBL] [Abstract][Full Text] [Related]
60. Relationship between the severity of enthesitis and clinical and laboratory parameters in patients with ankylosing spondylitis.
Kaya T; Bal S; Gunaydin R
Rheumatol Int; 2007 Feb; 27(4):323-7. PubMed ID: 17021712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
